glp 1 drugs and parkinson's disease The most extensive research to-date into the diabetes drug exenatide for the treatment of showed that the medication does not slow progression of the disease. The study, published in the February Beyond insulin: The Intriguing role

These metabolites influence the secretion pattern of gonadotropin-releasing hormone (GnRH) and disrupt the homeostasis of the hypothalamic-pituitary-ovarian axis (Longo et al., 2023

10.1186/1741-7015-2-13 80 McQuownS.XiaS.BaumgrtelK.BaridoR.AndersonG.DyckB.et al (2019)

Structural and mechanistic insights into dual activation of cagrilintide in amylin and [PMID: 40847076] Laboratory literature summary: Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors

These findings, in line with several recent studies reporting the protective effects of statins in various kidney diseases [42,43,44,45], underscore the critical role of lipid metabolic dysregulation in CaOx-induced renal injury and suggest that pharmacological modulation of lipid metabolism may serve as a complementary strategy to targeting the PRMT1/UBE2m axis